Q4 2015 Holdings
Filed 2016-02-09 | 134 holdings | $269.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | Common | 09062X103 | $138.0M | 450,533 | 51.2% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $62.5M | 596,145 | 23.2% |
| Acadia Pharmaceuticals Inc.(ACAD) | Common | 004225108 | $22.7M | 637,500 | 8.4% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $12.9M | 137,495 | 4.8% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $11.6M | 639,370 | 4.3% |
| CytomX Therapeutics, Inc.(CTMX) | Common | 23284F105 | $6.8M | 328,059 | 2.5% |
| Cellectis S.A.(CLLS) | Sponsored ADS | 15117K103 | $6.4M | 207,250 | 2.4% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $3.6M | 296,934 | 1.3% |
| Allscripts Healthcare Solutions, Inc.(MDRX) | Common | 01988P108 | $2.7M | 173,600 | 1.0% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $235.9K | 2,331,231 | 0.1% |
| Celgene Corporation(CELG) | Common | 151020104 | $205.2K | 1,713,634 | 0.1% |
| Vertex Pharmaceuticals Incorporated(VRTX) | Common | 92532F100 | $130.0K | 1,033,503 | 0.0% |
| Allergan plc | Shares | G0177J108 | $128.0K | 409,586 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $121.5K | 636,805 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $96.7K | 940,988 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $95.5K | 880,461 | 0.0% |
| Teva Pharmaceutical Industries Ltd.(TEVA) | ADR | 881624209 | $87.6K | 1,334,237 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $83.7K | 154,266 | 0.0% |
| Illumina Inc.(ILMN) | Common | 452327109 | $83.4K | 434,341 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $58.2K | 1,802,291 | 0.0% |
| Amgen Inc.(AMGN) | Common | 031162100 | $52.2K | 321,640 | 0.0% |
| UnitedHealth Group, Inc.(UNH) | Common | 91324P102 | $48.1K | 409,100 | 0.0% |
| Alkermes plc(ALKS) | Shares | G01767105 | $40.5K | 510,444 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $36.0K | 681,097 | 0.0% |
| Shire plc | Sponsored ADR | 82481R106 | $35.2K | 171,813 | 0.0% |
| Medivation, Inc. | Common | 58501N101 | $32.3K | 667,300 | 0.0% |
| Agilent Technologies, Inc.(A) | Common | 00846U101 | $30.5K | 728,650 | 0.0% |
| HCA Holdings, Inc.(HCA) | Common | 40412C101 | $30.3K | 448,488 | 0.0% |
| Mylan NV | Shares Euro | N59465109 | $28.7K | 531,252 | 0.0% |
| Humana Inc.(HUM) | Common | 444859102 | $23.1K | 129,300 | 0.0% |
| Molina Healthcare, Inc.(MOH) | Common | 60855R100 | $20.9K | 347,901 | 0.0% |
| Ventas, Inc.(VTR) | Common | 92276F100 | $20.8K | 369,266 | 0.0% |
| Physicians Realty Trust(DOCUSD) | Common | 71943U104 | $20.8K | 1,230,772 | 0.0% |
| Puma Biotechnology, Inc.(PBYI) | Common | 74587V107 | $20.4K | 260,200 | 0.0% |
| Ishares Nasdaq Biotechnology ETF(IBB) | ETF | 464287556 | $19.5K | 57,670 | 0.0% |
| Medical Properties Trust, Inc.(MPT) | Common | 58463J304 | $18.0K | 1,564,060 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $17.6K | 311,460 | 0.0% |
| Endo International plc | Shares | G30401106 | $17.5K | 286,348 | 0.0% |
| Novo Nordisk A/S(NVO) | ADR | 670100205 | $17.1K | 294,600 | 0.0% |
| McKesson Corporation(MCK) | Common | 58155Q103 | $16.3K | 82,862 | 0.0% |
| Horizon Pharma plc | Common | G4617B105 | $16.3K | 749,900 | 0.0% |
| St. Jude Medical, Inc. | Common | 790849103 | $15.8K | 255,810 | 0.0% |
| The Medicines Company | Common | 584688105 | $15.0K | 401,970 | 0.0% |
| Impax Laboratories, Inc. | Common | 45256B101 | $14.7K | 344,683 | 0.0% |
| United Therapeutics Corporation(UTHR) | Common | 91307C102 | $14.6K | 93,100 | 0.0% |
| Paratek Pharmaceuticals, Inc. | Common | 699374302 | $14.5K | 762,581 | 0.0% |
| Omega Healthcare Investors Inc.(OHI) | Common | 681936100 | $14.5K | 413,116 | 0.0% |
| Bristol-Myers Squibb Co.(BMY) | Common | 110122108 | $13.9K | 202,600 | 0.0% |
| Corsicanto Ltd | Note 3.50% 1/15/32 | 220480AB3 | $13.3K | $14,700,000 | 0.0% |
| Sanofi(SNY) | Sponsored ADR | 80105N105 | $13.0K | 305,000 | 0.0% |